In recent years we have seen an increasing number of adverse event reports for three Novo Nordisk semaglutide-containing drugs -- Ozempic, Rybelsus, and Wegovy -- that involve severe stomach conditions, including: Gastroparesis Gastric Stasis Stomach Paralysis The most common symptoms … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Case Evaluations — Free. Confidential. No Obligation.
➤ Information About Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Collection of Our “Side Effects” Blog Articles
Please know that you can use our Quick Contact Form to tell us about your case.
Recent News & Case Reports
Ozempic-Related Gastroparesis, Stomach Paralysis, Intestinal Blockages
In the several years since Ozempic was approved by the FDA, there have been adverse event reports of Ozempic-related gastroparesis, stomach paralysis, and intestinal blockage cases in patients using Ozempic. Gastroparesis may also be called delayed gastric emptying. Gastroparesis is a long-term, … More
Syfovre Eye Injections Adverse Reactions Update August 2023
We have some new information about Syfovre eye injections adverse reactions causing vision loss and blindness from Apellis Pharmaceuticals and the American Society of Retina Specialists (ASRS). Apellis said that it has confirmed seven cases of Syfovre eye injections adverse reactions. More … More
Tepezza-Related Hearing Problems Warning July 2023
A warning about the risks of Tepezza-related hearing problems was finally added to the Tepezza drug label in July 2023. Some of the various hearing problems associated with Tepezza can cause hearing loss and can be permanent. In more detail, in the current Tepezza Full Prescribing Information … More
Syfovre Vision Loss Cases Reported In Patients After Their First Injection
Syfovre vision loss cases have been reported by patients after the first time they used this injection treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). In mid-July 2023 the American Society of Retinal Specialists (ASRS) issued a warning letter about … More
Ozempic Drug Safety Issues Update: July 2023 Edition
In this Ozempic drug safety issues update we report on suicidal thoughts, thyroid cancer, and gallbladder disease as being possible Ozempic side effects. The European Medicines Agency (EMA) recently announced it has begun an investigation into Ozempic and suicidal thoughts as well as self-harm. … More